NASDAQ:MLAB - Mesa Laboratories Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$226.22 -5.87 (-2.53 %)
(As of 03/22/2019 04:00 PM ET)
Previous Close$226.22
Today's Range$226.01 - $233.58
52-Week Range$131.51 - $241.83
Volume38,495 shs
Average Volume24,403 shs
Market Capitalization$875.02 million
P/E Ratio36.61
Dividend Yield0.28%
Beta0.38
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness. This segment's products are used in healthcare, pharmaceutical, medical device, food and beverage, industrial hygiene, and environmental air sampling industries. Its Sterilization and Disinfection Control segment manufactures and markets biological indicators comprising spore strips, self-contained products, and culture media, as well as process challenge devices; and testing services. This segment also distributes chemical indicators that are used to assess the effectiveness of sterilization processes; and cleaning indicators, which are used to assess the effectiveness of cleaning processes. The company's Cold Chain Monitoring segment offers systems, which are used to monitor various environmental parameters, such as temperature, humidity, and differential pressure for use in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments; parameter monitoring services for products in a cold chain; and consulting services. Its Cold Chain Packaging segment offers packaging development consulting services and thermal packaging products. The company markets its products through distributors in Europe, Africa, Asia, South America, Australia, Canada, and Central America. Mesa Laboratories, Inc. was founded in 1982 and is headquartered in Lakewood, Colorado.

Receive MLAB News and Ratings via Email

Sign-up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Process control instruments
Sub-IndustryElectronic Equipment & Instruments
SectorMedical
Current SymbolNASDAQ:MLAB
CUSIP59064R10
Phone303-987-8000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$96.18 million
Cash Flow$8.6179 per share
Book Value$26.26 per share

Profitability

Net Income$-2,960,000.00

Miscellaneous

EmployeesN/A
Market Cap$875.02 million
Next Earnings Date6/4/2019 (Estimated)
OptionableNot Optionable

Mesa Laboratories (NASDAQ:MLAB) Frequently Asked Questions

What is Mesa Laboratories' stock symbol?

Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."

How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?

Mesa Laboratories declared a quarterly dividend on Wednesday, January 2nd. Investors of record on Thursday, February 28th will be given a dividend of $0.16 per share on Friday, March 15th. This represents a $0.64 dividend on an annualized basis and a yield of 0.28%. The ex-dividend date of this dividend is Wednesday, February 27th. View Mesa Laboratories' Dividend History.

How were Mesa Laboratories' earnings last quarter?

Mesa Laboratories, Inc. (NASDAQ:MLAB) announced its quarterly earnings results on Monday, February, 4th. The medical instruments supplier reported $1.69 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.68 by $0.01. The medical instruments supplier had revenue of $26.68 million for the quarter, compared to the consensus estimate of $25.80 million. Mesa Laboratories had a return on equity of 23.53% and a net margin of 9.98%. View Mesa Laboratories' Earnings History.

When is Mesa Laboratories' next earnings date?

Mesa Laboratories is scheduled to release their next quarterly earnings announcement on Tuesday, June 4th 2019. View Earnings Estimates for Mesa Laboratories.

What is the consensus analysts' recommendation for Mesa Laboratories?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mesa Laboratories in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Mesa Laboratories.

Has Mesa Laboratories been receiving favorable news coverage?

Media coverage about MLAB stock has been trending somewhat positive this week, according to InfoTrie Sentiment. The research firm identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Mesa Laboratories earned a news impact score of 1.5 on InfoTrie's scale. They also assigned press coverage about the medical instruments supplier a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an impact on the company's share price in the next few days.

Who are some of Mesa Laboratories' key competitors?

What other stocks do shareholders of Mesa Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mesa Laboratories investors own include NVIDIA (NVDA), Micron Technology (MU), Intel (INTC), Alibaba Group (BABA), Verizon Communications (VZ), Coupa Software (COUP), Employers (EIG), Control4 (CTRL), Appian (APPN) and Exelixis (EXEL).

Who are Mesa Laboratories' key executives?

Mesa Laboratories' management team includes the folowing people:
  • Mr. Gary M. Owens, CEO, Pres & Director (Age 51)
  • Mr. John V. Sakys, Chief Financial Officer, Chief Accounting Officer, Sec. & Treasurer (Age 50)
  • Mr. Gregory T. DiNoia, Sr. VP of Commercial Operations (Age 54)
  • Ms. Helene R. Leone, Gen. Counsel
  • Mr. Peter Jung, VP of Corp. Devel. & Strategy

Who are Mesa Laboratories' major shareholders?

Mesa Laboratories' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Conestoga Capital Advisors LLC (12.63%), BlackRock Inc. (6.53%), Ranger Investment Management L.P. (4.06%), Kayne Anderson Rudnick Investment Management LLC (4.04%), Dimensional Fund Advisors LP (3.64%) and Dimensional Fund Advisors LP (3.64%). Company insiders that own Mesa Laboratories stock include David M Kelly, Evan Guillemin, Glenn E Adriance, H Stuart Campbell, John Bradley Schmieder, John James Sullivan, John Sakys, Michael T Brooks, Robert V Dwyer and Seg Ventures, Llc. View Institutional Ownership Trends for Mesa Laboratories.

Which institutional investors are selling Mesa Laboratories stock?

MLAB stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Royce & Associates LP, Brown Advisory Inc., Barclays PLC, Bank of New York Mellon Corp, Thomson Horstmann & Bryant Inc., Bahl & Gaynor Inc. and MetLife Investment Advisors LLC. Company insiders that have sold Mesa Laboratories company stock in the last year include David M Kelly, Evan Guillemin, H Stuart Campbell, John Bradley Schmieder, John James Sullivan, John Sakys, Michael T Brooks and Robert V Dwyer. View Insider Buying and Selling for Mesa Laboratories.

Which institutional investors are buying Mesa Laboratories stock?

MLAB stock was bought by a variety of institutional investors in the last quarter, including Atlanta Capital Management Co. L L C, Ranger Investment Management L.P., BlackRock Inc., Massachusetts Financial Services Co. MA, Bank of America Corp DE, Conestoga Capital Advisors LLC, Northern Trust Corp and Public Employees Retirement System of Ohio. View Insider Buying and Selling for Mesa Laboratories.

How do I buy shares of Mesa Laboratories?

Shares of MLAB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Mesa Laboratories' stock price today?

One share of MLAB stock can currently be purchased for approximately $226.22.

How big of a company is Mesa Laboratories?

Mesa Laboratories has a market capitalization of $875.02 million and generates $96.18 million in revenue each year. The medical instruments supplier earns $-2,960,000.00 in net income (profit) each year or $6.18 on an earnings per share basis.

What is Mesa Laboratories' official website?

The official website for Mesa Laboratories is http://www.mesalabs.com.

How can I contact Mesa Laboratories?

Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The medical instruments supplier can be reached via phone at 303-987-8000 or via email at [email protected]


MarketBeat Community Rating for Mesa Laboratories (NASDAQ MLAB)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  167 (Vote Outperform)
Underperform Votes:  144 (Vote Underperform)
Total Votes:  311
MarketBeat's community ratings are surveys of what our community members think about Mesa Laboratories and other stocks. Vote "Outperform" if you believe MLAB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MLAB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel